14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
CYRX vs SLGB: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, CryoPort, Inc. (CYRX) is the stronger overall head-to-head candidate over SLGB (SLGB) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Options & Positioning). CYRX carries a Unified Composite Score of 39.7/100 (SELL) at $19.64 (93.5x Forward P/E, -14.4% operating margin), whereas SLGB carries 47.2/100 (HOLD) at $0.18 (N/M Forward P/E, -2.3% operating margin).
Composite vs. Pillar Nuance: While SLGB currently prints a higher short-term Unified Composite Score (47.2/100 HOLD vs. CYRX 39.7/100 SELL), CYRX captures the overall institutional head-to-head verdict (7–3 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (-14.4% vs. -2.3% operating margin) and revenue trajectory (+13.5% vs. -22.1% YoY).
Technical & Structure Timing Caution: CYRX trades in a Markup technical trend (BREAKOUT options phase, RSI 59.1); meanwhile SLGB is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 38.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CYRX vs SLGB. Trailing 12-month operating profitability (CYRX -14.4% vs SLGB -2.3%) and valuation multiples (CYRX 93.5x vs SLGB N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Integrated Freight & Logistics value chain with $8.1M market capitalization and -2.3% operating margin.
OpEx & R&D Reinvestment7.0% of Rev ($44M)
90D Engineering Disclosures0 Published
Investor FAQ CYRX vs SLGB Key Questions & Quantitative Answers
As of Nov 16, 2026, CryoPort, Inc. (CYRX) is the stronger overall head-to-head candidate over SLGB (SLGB) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Options & Positioning). CYRX carries a Unified Composite Score of 39.7/100 (SELL) at $19.64 (93.5x Forward P/E, -14.4% operating margin), whereas SLGB carries 47.2/100 (HOLD) at $0.18 (N/M Forward P/E, -2.3% operating margin). Composite vs. Pillar Nuance: While SLGB currently prints a higher short-term Unified Composite Score (47.2/100 HOLD vs. CYRX 39.7/100 SELL), CYRX captures the overall institutional head-to-head verdict (7–3 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (-14.4% vs. -2.3% operating margin) and revenue trajectory (+13.5% vs. -22.1% YoY). Technical & Structure Timing Caution: CYRX trades in a Markup technical trend (BREAKOUT options phase, RSI 59.1); meanwhile SLGB is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 38.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
CYRX leads the Growth & Scale pillar: CYRX posts +13.5% YoY revenue growth and +0.0% YoY earnings growth on $192M TTM revenue (46.9% gross margin, -14.4% operating margin), compared with SLGB at -22.1% YoY revenue growth and +356.9% YoY earnings growth on $629M TTM revenue (4.7% gross margin, -2.3% operating margin). On trailing 12-month operating scale, CYRX generates $192M in USD-normalized revenue versus $629M for SLGB. In operating R&D and SG&A reinvestment, CYRX deploys 61.3% of Rev ($118M) (0 90-day corporate R&D disclosures) versus 7.0% of Rev ($44M) (0 disclosures) for SLGB.
CYRX screens cheaper on headline valuation multiples. CYRX trades at 93.5x Forward P/E, 93.5x Trailing P/E, N/M PEG, and 5.0x EV/Revenue (-10.3% FCF margin), whereas SLGB trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (-2.0% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CYRX (-7.4% ROE) versus SLGB (-14.7% ROE) capital efficiency.
In options market volatility and institutional positioning, CYRX carries 44.3% implied volatility (6th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a BREAKOUT options structure phase (1.58β · 85% Vol realized risk). By comparison, SLGB carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.05β · 207% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.